Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Fresenius takes full ownership of mAbxience in biosimilars push
Dealroom.co1 min read
Fresenius takes full ownership of mAbxience in biosimilars push Dealroom
Read the full article at Dealroom.coRelated coverage
Bluesky’s new CEO wants a big tent, not a bubble
The Verge · Aug 3, 2026
AI Products
A Deep Dive into LDS Optimizations on AMD Instinct MI450 GPUs
AMD · Aug 28, 2026
AI Products
Presentation: Platform Teams Enabling AI - MCP/Multi-Agentic Tools across Linkedin
InfoQ · Jun 5, 2026
AI Products
[AINews] High Taste Testers Ep. 1
Latent Space · Oct 17, 2026